Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q4 2025 vs. Q3 2025
How the institutions holding Titan Pharmaceuticals Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 18 | 4 | −14 |
| Shares | 22.4K | 92 | −22.3K (−99.6%) |
| Value | $107.1K | $154 | −$107.0K (−99.9%) |
New holders (0)
Institutions that held Titan Pharmaceuticals Inc at the end of Q4 2025 but not at the end of Q3 2025.
None.
Sold out (14)
Institutions that held Titan Pharmaceuticals Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| DRW Securities, LLC | 21,267 | $101.9K |
| UBS Group AG | 480 | $2.30K |
| Tower Research Capital LLC (TRC) | 469 | $2.25K |
| Bank of America Corp | 19 | $91 |
| Group One Trading, L.P. | 12 | $58 |
| Advisor Group Holdings, Inc. | 10 | $35 |
| BlackRock, Inc. | 6 | $29 |
| Morgan Stanley | 2 | $10 |
| Wells Fargo & Company | 1 | $5 |
| Westside Investment Management, Inc. | 1 | $5 |
| SBI Securities Co., Ltd. | 1 | $5 |
| Nemes Rush Group LLC | 1 | $5 |
| Ransom Advisory, Ltd | 1 | $5 |
| CWM, LLC | 1 | $0 |